# Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

> **NCT00199862** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Colorectal Cancer
- Colorectal Tumor
- COlorectal Carcinoma

## Interventions

- **DRUG:** Iodine-124 labeled humanized A33 (antibody)

## Key facts

- **NCT ID:** NCT00199862
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2025-07-02
- **Final completion:** 2025-07-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00199862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00199862, "Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00199862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*